These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 19649903)

  • 1. Scaling-up production of recombinant AAV vectors for clinical applications.
    Qu G; McClelland A; Wright JF
    Curr Opin Drug Discov Devel; 2000 Nov; 3(6):750-5. PubMed ID: 19649903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and characterization of a cell line for large-scale, serum-free production of recombinant adeno-associated viral vectors.
    Farson D; Harding TC; Tao L; Liu J; Powell S; Vimal V; Yendluri S; Koprivnikar K; Ho K; Twitty C; Husak P; Lin A; Snyder RO; Donahue BA
    J Gene Med; 2004 Dec; 6(12):1369-81. PubMed ID: 15538729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adeno-associated virus as a gene therapy vector: vector development, production and clinical applications.
    Grieger JC; Samulski RJ
    Adv Biochem Eng Biotechnol; 2005; 99():119-45. PubMed ID: 16568890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant adeno-associated virus: formulation challenges and strategies for a gene therapy vector.
    Wright JF; Qu G; Tang C; Sommer JM
    Curr Opin Drug Discov Devel; 2003 Mar; 6(2):174-8. PubMed ID: 12669452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromatographic purification of recombinant adenoviral and adeno-associated viral vectors: methods and implications.
    Burova E; Ioffe E
    Gene Ther; 2005 Oct; 12 Suppl 1():S5-17. PubMed ID: 16231055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced preparation of adeno-associated viral vectors by using high hydrostatic pressure to selectively inactivate helper adenovirus.
    Leonard JN; Ferstl P; Delgado A; Schaffer DV
    Biotechnol Bioeng; 2007 Aug; 97(5):1170-9. PubMed ID: 17252611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary recovery and chromatographic purification of adeno-associated virus type 2 produced by baculovirus/insect cell system.
    Chahal PS; Aucoin MG; Kamen A
    J Virol Methods; 2007 Jan; 139(1):61-70. PubMed ID: 17055590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production and characterization of adeno-associated viral vectors.
    Grieger JC; Choi VW; Samulski RJ
    Nat Protoc; 2006; 1(3):1412-28. PubMed ID: 17406430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Manufacturing and characterizing AAV-based vectors for use in clinical studies.
    Wright JF
    Gene Ther; 2008 Jun; 15(11):840-8. PubMed ID: 18418418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-titer, serum-free production of adeno-associated virus vectors by polyethyleneimine-mediated plasmid transfection in mammalian suspension cells.
    Hildinger M; Baldi L; Stettler M; Wurm FM
    Biotechnol Lett; 2007 Nov; 29(11):1713-21. PubMed ID: 17636388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scalable serum-free production of recombinant adeno-associated virus type 2 by transfection of 293 suspension cells.
    Durocher Y; Pham PL; St-Laurent G; Jacob D; Cass B; Chahal P; Lau CJ; Nalbantoglu J; Kamen A
    J Virol Methods; 2007 Sep; 144(1-2):32-40. PubMed ID: 17467815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large-scale production, purification and crystallization of wild-type adeno-associated virus-2.
    Xie Q; Hare J; Turnigan J; Chapman MS
    J Virol Methods; 2004 Dec; 122(1):17-27. PubMed ID: 15488616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioreactor production of recombinant herpes simplex virus vectors.
    Knop DR; Harrell H
    Biotechnol Prog; 2007; 23(3):715-21. PubMed ID: 17461549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PEG-modulated column chromatography for purification of recombinant adeno-associated virus serotype 9.
    Zhou J; Yang X; Wright JF; High KA; Couto L; Qu G
    J Virol Methods; 2011 Apr; 173(1):99-107. PubMed ID: 21295608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromatography-based purification of adeno-associated virus.
    Smith RH; Yang L; Kotin RM
    Methods Mol Biol; 2008; 434():37-54. PubMed ID: 18470638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large-scale production of recombinant adeno-associated viral vectors.
    Negrete A; Kotin RM
    Methods Mol Biol; 2008; 433():79-96. PubMed ID: 18679618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adeno-associated virus-mediated gene delivery approaches for the treatment of CNS disorders.
    Terzi D; Zachariou V
    Biotechnol J; 2008 Dec; 3(12):1555-63. PubMed ID: 19072910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a scalable process for high-yield lentiviral vector production by transient transfection of HEK293 suspension cultures.
    Ansorge S; Lanthier S; Transfiguracion J; Durocher Y; Henry O; Kamen A
    J Gene Med; 2009 Oct; 11(10):868-76. PubMed ID: 19618482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification of retroviral vectors for clinical application: biological implications and technological challenges.
    Rodrigues T; Carrondo MJ; Alves PM; Cruz PE
    J Biotechnol; 2007 Jan; 127(3):520-41. PubMed ID: 16950534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adeno-associated viruses (AAV)].
    Małecki M; Woźniak A; Janik P
    Postepy Biochem; 2008; 54(1):57-63. PubMed ID: 18610582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.